Skip to main content
Caplight Logo









Deep Blue BioTech

Deep Blue BioTech

Private
StowmarketHealthcare & Life Scienceshttps://deepbluebiotech.com/

Last Round

Grant

Oct 20, 2025

Total Funding Raised

$1.65M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Deep Blue BioTech is a biotechnology company that develops a synthetic biology platform to produce carbon-neutral chemicals using photosynthetic cyanobacteria.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Fashion & Beauty

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

synthetic biologysynbiohyaluronic acidcyanobacteriasustainable ingredientscarbon-negativemetabolic modellingcosmetic ingredientsbiomanufacturinggreen chemistryclean beautybio-based chemicalssustainable supply chainfermentation technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deep Blue BioTech Comparables

Compare Deep Blue BioTech with similar companies based on industry and business-model similarity.

Deep Blue BioTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aura Life Science
82%
Enzymit
80%
Bravely Cultured
79%

Deep Blue BioTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 20, 2025
Pre SeedOct 29, 2024
AcceleratorJul 1, 2024
GrantFeb 1, 2024
Pre SeedOct 5, 2023
Accelerator
May 1, 2023

Deep Blue BioTech Investors

Notable investors and investment history

Deep Blue BioTech investors
InvestorRounds
Innovate UKGrant
Sustainable VenturesPre Seed
Innovate UKGrant
The GreenhouseAccelerator
SFC CapitalPre Seed
One Planet CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 146% MoM, reaching 1.5K.

  • Apr 15, 2026

    Monthly visitors increased 331% MoM.

Deep Blue BioTech Filings

Explore SEC and related filing metadata, where available.

Deep Blue BioTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Deep Blue BioTech's valuation, stock price, and market status.

Is Deep Blue BioTech a public or private company?

Deep Blue BioTech is a private company.

What is the current stock price of Deep Blue BioTech?

Deep Blue BioTech is a private company with no public stock price. No recent secondary market data is available.

How much is Deep Blue BioTech worth (valuation)?

Valuation information for Deep Blue BioTech is not publicly available.

Can I buy Deep Blue BioTech stock?

Deep Blue BioTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Deep Blue BioTech's last funding round?

Deep Blue BioTech's most recent funding round was Grant on October 20, 2025.

Who are the main investors in Deep Blue BioTech?

Key investors in Deep Blue BioTech include Innovate UK, The Greenhouse.

Will Deep Blue BioTech IPO soon?

No public IPO plans have been announced for Deep Blue BioTech.

How can I track Deep Blue BioTech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Deep Blue BioTech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStowmarket
Employee Range3
Year Founded2023
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?